[研究报告] 透粘膜给药系统市场规模预计将从 2023 年的 802.1 亿美元增长到 2031 年的 1294.6 亿美元;预计 2023 年至 2031 年的复合年增长率为 6.2%。
分析师观点
经粘膜给药涉及口腔粘膜、鼻粘膜、直肠粘膜、阴道粘膜、眼粘膜和肺粘膜等粘膜用于给药。生物利用度更高、起效迅速、避免首过代谢和给药方便是这种给药系统相对于传统给药途径的主要优势。该报告包括当前经粘膜给药系统市场趋势及其在预测期内可预见的影响带来的增长前景。
推动透粘膜给药系统市场增长的因素
由于这种给药方式具有持久的疗效,因此粘膜给药是一种首选的给药途径。鼻腔内、口腔、舌下和直肠等粘膜途径是全身给药的非侵入性方法。它们特别有用,因为护理人员或患者可以在不需要专业人员的情况下给药。此外,由于起效迅速,首过代谢减少,它们成为姑息治疗和临终关怀的理想选择。它们能快速缓解症状,为患者提供快速缓解。因此,粘膜给药系统已成为治疗各种慢性疾病(如心血管疾病、糖尿病和慢性呼吸系统疾病)的热门选择。根据 PubMed Central 于 2020 年 1 月发表的一篇文章,进行了一项研究,以调查和比较二氢麦角胺 (DHE) 在健康受试者中以鼻内 DHE 粉末 (STS101)、鼻内 DHE 喷雾剂 (Migranal) 和肌肉内 (IM) DHE 注射剂形式给药时的安全性和药代动力学。研究得出结论,STS101 是一种易于给药、非注射的偏头痛急性治疗药物,具有良好的耐受性。它还有望促进快速和持续的疼痛缓解,并抑制偏头痛症状而不会复发。
许多药理学药物都以口腔黏膜形式提供;这些药物包括心血管药物、镇静剂和止痛药。可生物降解的口腔薄膜有助于将药物输送到全身循环,这对患有吞咽困难、反复呕吐、高血压、心脏病发作、哮喘、恶心、瘫痪和精神障碍的患者非常有利。这些口腔速溶薄膜是薄的粘性条,可贴在患者的舌头或任何口腔黏膜组织上。
因此,易于管理、生物利用度高、全身药物可用性和快速作用等优势推动了透粘膜药物输送系统市场的增长。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
报告细分和范围
“2031 年全球透皮给药系统市场分析”是一项专门深入的制药行业研究,特别关注全球市场趋势分析。该报告旨在提供市场概览,并根据系统、最终用户和地理位置对市场进行详细细分。它提供了主要市场参与者的关键统计数据,并提到了市场中存在的关键趋势和机会。全球透皮给药系统市场报告的范围包括北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、澳大利亚、韩国和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
基于系统的见解
根据系统,市场细分为鼻肺给药、颊黏膜给药和舌下给药、阴道给药和其他给药。鼻肺给药在 2023 年占据了最大的透粘膜给药系统市场份额,预计在 2023 年至 2031 年期间将实现最高的复合年增长率。
基于最终用户的洞察
根据最终用户,市场细分为医疗机构、家庭护理环境和其他。医疗机构部分在 2023 年占据了最大的市场份额。这可以归因于医院拥有更好的设施和熟练的医生。此外,预计家庭护理环境部分在 2023 年至 2031 年期间的复合年增长率最高。
区域分析
根据地域划分,市场主要分为北美、亚太地区、欧洲、中东和非洲以及南美和中美洲。就收入而言,北美在 2023 年占据了最大的透皮给药系统市场份额。美国在该地区占据市场主导地位。这可以归因于糖尿病、哮喘和心脏病等慢性病病例的增加,以及主要参与者推出的产品数量不断增加。
透粘膜药物输送系统市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响透皮给药系统市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的透皮给药系统市场细分和地理分布。
- 获取透粘膜给药系统市场的区域特定数据
透粘膜给药系统市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 802.1亿美元 |
2031 年市场规模 | 1294.6亿美元 |
全球复合年增长率(2023 - 2031) | 6.2% |
史料 | 2021-2023 |
预测期 | 2023-2031 |
涵盖的领域 | 按系统
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
透粘膜给药系统市场参与者密度:了解其对业务动态的影响
透皮给药系统市场正在快速增长,这得益于终端用户需求的不断增长,这些需求源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明相对于给定市场空间的规模或总市场价值,有多少竞争对手(市场参与者)存在于该市场空间中。
在透粘膜药物输送系统市场运营的主要公司有:
- 梯瓦制药工业有限公司
- 信诺集团
- 生物递送科学国际公司
- 3M
- 汉高芬兰公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解透粘膜药物输送系统市场的主要参与者概况
行业发展和未来机遇:
透皮给药系统市场预测可以帮助该市场的利益相关者制定增长战略。根据公司新闻稿,以下列出了全球市场领先企业的一些战略发展:
- 2024年2月,Aquestive Therapeutics, Inc.在华盛顿特区举行的美国过敏、哮喘和免疫学学会(AAAAI)2024年年会上展示了一张海报,重点介绍了两项完整的舌下Anaphylm(肾上腺素)膜临床研究的积极药代动力学(PK)和药效学(PD)数据。
- 2022 年 8 月,iX Biopharma Ltd 启动了一项新项目 IXB-322,以扩大其产品线。该项目旨在开发一种舌下右美托咪啶薄片,用于治疗痴呆症和其他适应症中的躁动。该计划是 iX Biopharma 利用其专有的 WaferiX 药物输送平台技术重新利用现有已获批准药物的战略的一部分。
- 2021 年 5 月,日本 Zeria 集团旗下的 Tillotts Pharma AG 推出了 AsacolTM 1g(美沙拉嗪),为其胃肠病学产品组合增添了一款新药。这种高强度栓剂用于治疗成人轻度至中度溃疡性直肠炎症状。此次推出将有助于该公司为胃肠道疾病患者提供创新疗法。AsacolTM 1g 栓剂为溃疡性直肠炎患者提供了一种方便的治疗方式,因为他们每天只需服用一次。
- 2021年4月,梯瓦制药工业有限公司(Teva Pharmaceutical Industries Ltd.)美国子公司Teva Pharmaceuticals USA, Inc.宣布推出Casana 1(美沙拉嗪)栓剂仿制药,该药在美国用于治疗活动性溃疡性直肠炎(溃疡性直肠结肠炎)。
Teva Pharmaceutical Industries Ltd;Cigna Corporation.;BioDelivery Sciences International, Inc;3M;Henkel Finland Oy;GlaxoSmithKline plc;Aquestive Therapeutics, Inc;Camurus AB;Ximedica;以及 Noven Pharmaceuticals, Inc 是透皮给药系统市场报告中介绍的几家主要公司。这些领先企业专注于扩大和多样化其市场占有率和客户群,挖掘市场中的商机。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The transmucosal drug delivery systems market is expected to be valued at US$ 129.46 billion in 2031.
The transmucosal drug delivery systems market, by systems, is bifurcated into nasopulmonary, buccal & sublingual, vaginal, and others. The nasopulmonary segment held a larger market share in 2023.
The transmucosal drug delivery systems market was valued at US$ 80.21 billion in 2023.
The transmucosal drug delivery systems market majorly consists of the players, including Teva Pharmaceutical Industries Ltd; Cigna Corporation.; BioDelivery Sciences International, Inc; 3M; Henkel Finland Oy; GlaxoSmithKline plc; Aquestive Therapeutics, Inc; Camurus AB; Ximedica; and Noven Pharmaceuticals, Inc.
Key factors driving the transmucosal drug delivery systems market growth is rising adoption of drug delivery systems for disease management and the development of new drug molecules and biological formulations.
The transmucosal drug delivery involves mucosal membranes such as oral mucosa, nasal mucosa, rectal mucosa, vaginal mucosa, ocular mucosa, and pulmonary mucosa for drug administration. Higher bioavailability, rapid onset of action, evasion of first-pass metabolism, and ease of administration are the key advantages of this drug delivery system over traditional routes of drug administration.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Transmucosal Drug Delivery Systems Market
- Teva Pharmaceutical Industries Ltd
- Cigna Corporation
- BioDelivery Sciences International, Inc
- 3M
- Henkel Finland Oy
- GlaxoSmithKline plc
- Aquestive Therapeutics, Inc
- Camurus AB
- Ximedica
- Noven Pharmaceuticals, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.